Title : Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

Pub. Date : 2011 Aug 25

PMID : 21670470






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patients with fludarabine-refractory disease and 17p deletion. fludarabine CD52 molecule Homo sapiens